(ASRNL) ASR Nederland - Overview
Sector: Financial Services | Industry: Insurance - Diversified | Exchange: AS (Netherlands) | Market Cap: 13.956m EUR | Total Return: 21.9% in 12m
Insurance, Pensions, Mortgages, Asset Management
Total Rating 46
Safety 19
Buy Signal -0.06
Insurance - Diversified
Industry Rotation: +5.0
Industry Rotation: +5.0
Market Cap:
16.2B
Avg Turnover: 32.3M
Avg Turnover: 32.3M
Risk 3d forecast
Volatility18.0%
VaR 5th Pctl3.15%
VaR vs Median6.18%
Reward TTM
Sharpe Ratio1.07
Rel. Str. IBD55.7
Rel. Str. Peer Group76.7
Character TTM
Beta0.255
Beta Downside-0.003
Hurst Exponent0.425
Drawdowns 3y
Max DD19.40%
CAGR/Max DD1.37
CAGR/Mean DD7.46
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: ASRNL ASR Nederland
ASR Nederland N.V. is a Dutch financial services provider specializing in insurance, pensions, and mortgages. The company operates across five primary segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. Its portfolio includes disability, property and casualty, health, and funeral insurance, alongside pension products and individual term life policies.
The business model relies on a multi-brand strategy, utilizing names such as a.s.r. and Aegon to penetrate the residential mortgage market. As a multi-line insurer, ASR Nederland benefits from diversified revenue streams, balancing the shorter-term underwriting cycles of non-life products with the long-term capital management requirements of life and pension segments. The company also manages an extensive real estate and renewable energy asset portfolio, including wind and solar farms.
Historical data and valuation metrics on ValueRay can help clarify how these segments contribute to long-term growth. Founded in 1720 and headquartered in Utrecht, the firm maintains a significant presence in the Dutch domestic market through both direct services and specialized advisory brands focused on occupational health and reintegration.
- Integration of Aegon Netherlands assets accelerates cost synergies and market share growth
- Solvency II ratio fluctuations impact capital return and dividend payout sustainability
- Dutch mortgage market volatility influences asset management fees and interest margins
- Regulatory shifts in pension reform affect long-term life insurance liability management
- Rising claims inflation in non-life segments pressures technical margins and pricing power
Piotroski VR‑10 (Strict)
4.0
| Net Income: 1.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -4.45 > 1.0 |
| NWC/Revenue: -43.38% < 20% (prev 16.85%; Δ -60.23% < -1%) |
| CFO/TA -0.01 > 3% & CFO -1.27b > Net Income 1.47b |
| Net Debt (7.71b) to EBITDA (14.80b): 0.52 < 3 |
| Current Ratio: 0.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.5m) vs 12m ago -11.93% < -2% |
| Gross Margin: 84.32% > 18% (prev 1.00%; Δ 8.33k% > 0.5%) |
| Asset Turnover: 20.56% > 50% (prev 13.01%; Δ 7.55% > 0%) |
| Interest Coverage Ratio: 0.84 > 6 (EBITDA TTM 14.80b / Interest Expense TTM 9.88b) |
Altman Z''
-0.08
| A: -0.09 (Total Current Assets 3.06b - Total Current Liabilities 16.12b) / Total Assets 142.15b |
| B: 0.03 (Retained Earnings 4.34b / Total Assets 142.15b) |
| C: 0.06 (EBIT TTM 8.31b / Avg Total Assets 146.46b) |
| D: 0.04 (Book Value of Equity 4.82b / Total Liabilities 133.53b) |
| Altman-Z'' = -0.08 = B |
Beneish M
1.00
| DSRI: 13.45 (Receivables 351.0m/17.0m, Revenue 30.11b/19.61b) |
| GMI: 1.18 (GM 84.32% / 99.87%) |
| AQI: 1.06 (AQ_t 0.97 / AQ_t-1 0.92) |
| SGI: 1.54 (Revenue 30.11b / 19.61b) |
| TATA: 0.02 (NI 1.47b - CFO -1.27b) / TA 142.15b) |
| Beneish M = 7.82 (Cap -4..+1) = D |
What is the price of ASRNL shares?
As of May 22, 2026, the stock is trading at EUR 67.12 with a total of 711,808 shares traded.
Over the past week, the price has changed by -1.00%, over one month by +4.84%, over three months by +7.60% and over the past year by +21.94%.
Over the past week, the price has changed by -1.00%, over one month by +4.84%, over three months by +7.60% and over the past year by +21.94%.
Is ASRNL a buy, sell or hold?
ASR Nederland has no consensus analysts rating.
What are the forecasts/targets for the ASRNL price?
| Analysts Target Price | - | - |
ASR Nederland (ASRNL) - Fundamental Data Overview
as of 19 May 2026
Market Cap USD = 16.22b (13.96b EUR * 1.1625 EUR.USD)P/E Trailing = 31.2685
P/E Forward = 10.9051
P/S = 0.815
P/B = 1.3146
Revenue TTM = 30.11b EUR
EBIT TTM = 8.31b EUR
EBITDA TTM = 14.80b EUR
Long Term Debt = 8.91b EUR (from longTermDebt, last quarter)
Short Term Debt = 70.0m EUR (from shortTermDebt, last fiscal year)
Debt = 10.42b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.71b EUR (from netDebt column, last quarter)
Enterprise Value = 21.67b EUR (13.96b + Debt 10.42b - CCE 2.71b)
Interest Coverage Ratio = 0.84 (Ebit TTM 8.31b / Interest Expense TTM 9.88b)
EV/FCF = -16.53x (Enterprise Value 21.67b / FCF TTM -1.31b)
FCF Yield = -6.05% (FCF TTM -1.31b / Enterprise Value 21.67b)
FCF Margin = -4.35% (FCF TTM -1.31b / Revenue TTM 30.11b)
Net Margin = 4.87% (Net Income TTM 1.47b / Revenue TTM 30.11b)
Gross Margin = 84.32% ((Revenue TTM 30.11b - Cost of Revenue TTM 4.72b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.15 (Enterprise Value 21.67b / Total Assets 142.15b)
Interest Expense / Debt = 28.44% (Interest Expense 2.96b / Debt 10.42b)
Taxrate = 18.18% (96.0m / 528.0m)
NOPAT = 6.80b (EBIT 8.31b * (1 - 18.18%))
Current Ratio = 0.19 (Total Current Assets 3.06b / Total Current Liabilities 16.12b)
Debt / Equity = 1.21 (Debt 10.42b / totalStockholderEquity, last quarter 8.60b)
Debt / EBITDA = 0.52 (Net Debt 7.71b / EBITDA 14.80b)
Debt / FCF = -5.88 (negative FCF - burning cash) (Net Debt 7.71b / FCF TTM -1.31b)
Total Stockholder Equity = 9.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.00% (Net Income 1.47b / Total Assets 142.15b)
RoE = 15.64% (Net Income TTM 1.47b / Total Stockholder Equity 9.37b)
RoCE = 45.43% (EBIT 8.31b / Capital Employed (Equity 9.37b + L.T.Debt 8.91b))
RoIC = 35.59% (NOPAT 6.80b / Invested Capital 19.10b)
WACC = 13.89% (E(13.96b)/V(24.38b) * Re(6.88%) + D(10.42b)/V(24.38b) * Rd(28.44%) * (1-Tc(0.18)))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 46.00 | Cagr: 19.53%
[DCF] Fair Price = unknown (Cash Flow -1.31b)
EPS Correlation: -60.73 | EPS CAGR: -24.20% | SUE: N/A | # QB: 0
Revenue Correlation: 91.10 | Revenue CAGR: 29.92% | SUE: 0.88 | # QB: 0
EPS current Year (2026-12-31): EPS=6.09 | Chg30d=+0.00% | Revisions=-20% | GrowthEPS=-4.2% | GrowthRev=+18.7%
EPS next Year (2027-12-31): EPS=6.24 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+2.6% | GrowthRev=-7.3%
[Analyst] Revisions Ratio: -20%